Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
about
Targeting the insulin-like growth factor pathway in hepatocellular carcinomaFrequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinomaFrequent loss of imprinting of IGF2 and MEST in lung adenocarcinomaEnvironmental exposures and gene regulation in disease etiologyMicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.The Role of Long Non-Coding RNAs in Ovarian Cancer.IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics.Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskLoss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.Genomic imprinting mechanisms in mammals.Multi-biomarker pattern for tumor identification and prognosis.Long noncoding RNAs: a potential novel class of cancer biomarkers.The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric CarcinogenesisDevelopment of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequencesEffect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.Polymorphism in IGF-2 as a surrogate marker for predisposition towards tobacco chewing-mediated oral cancer.Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma.Intergenerational response to the endocrine disruptor vinclozolin is influenced by maternal genotype and crossing scheme.Epigenetic Mechanisms in Cancer Formation and Progression
P2860
Q27006846-348F12A4-F38E-485C-81CB-83FC93D9FC0BQ28140252-C48CC8E4-6871-4192-8003-F2FAF64E4CC5Q28215251-AF0CF883-8F29-433C-A0BF-C24A4FCEC4C6Q28757092-9D1F2DAC-4D72-444E-B0B7-3C2FEB2AE915Q30244282-6001D647-025F-40D3-B590-B4F9CA077266Q30245117-E021DEE5-710F-4955-B5CC-CC56248670A2Q34784791-194918B5-C65B-4B3E-9891-46F9ABA57E1BQ34955369-4F4BC425-3344-439D-BCAA-8A5C2D558F56Q35722177-C2EF0D75-8525-4E58-AB9F-E36BE38C323AQ36116407-4C072270-BFAB-49C5-ACA3-3A264A36BB05Q36835706-ECFB636A-F36D-46B8-9737-2DB970ED5F09Q37105077-8411A84F-69C1-4092-8981-80A0774DB453Q37890322-2F3CEC75-D869-45FE-A315-15FC0AD3362EQ38466810-0B8AF892-86CE-412C-9FDD-6B241282E591Q39147883-9F5D787F-06DD-4F77-BAF0-4D99664F9E16Q42049338-B7EFA70C-C883-48C7-B40B-1C6D64ECA7C4Q44153699-858E5529-7307-4A8A-AE1B-520744DDA75BQ46300666-D91945E4-84A1-4DD5-85E4-B3261094A340Q47626062-519173EF-484D-428B-AC00-1DDD1B4B314DQ49744006-83FB279C-23EB-4AEB-8585-5F8C7E103E4AQ52657456-2EEF2110-9EA9-496C-B392-98EBCBCE6695Q57570317-DEE2FE18-7B28-4746-97A1-BCC3A50B2EAF
P2860
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@en
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@nl
type
label
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@en
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@nl
prefLabel
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@en
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@nl
P2093
P2860
P1476
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1096-8628(19981204)80:4<391::AID-AJMG16>3.0.CO;2-H
P577
1998-12-01T00:00:00Z